Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Human Genetics and Genomic Medicine, |
RCV002226630 | SCV002505379 | uncertain significance | Combined oxidative phosphorylation deficiency 55 | 2022-04-25 | criteria provided, single submitter | clinical testing | The detected change is reported in the dbSNP database (dbSNP151 as of 04/25/2022) with the designation rs764240322. In gnomAD it is listed with a frequency of 0.002144% (5/233172) (as of April 25, 2022). Bioinformatically, the change is classified inconsistently as "probably disease-causing" (CADDphred 33) or as more benign (mutation taster). Since this is a highly conserved amino acid, the variant may have an influence on the function of the protein. Based on the current state of knowledge, the variant can be classified as a “variant of uncertain clinical significance” (ACMG criteria). |